Optimized Radiomics Nomogram Based on Automated Breast Ultrasound System: A Potential Tool for Preoperative Prediction of Metastatic Lymph Node Burden in Breast Cancer
Ning Li,Chao Song,Xian Huang,Hongjiang Zhang,Juan Su,Lichun Yang,Juhua He,Guihua Cui
DOI: https://doi.org/10.2147/BCTT.S398300
2023-02-04
Breast Cancer: Targets and Therapy
Abstract:Ning Li, 1, &ast Chao Song, 2 Xian Huang, 3, &ast Hongjiang Zhang, 1 Juan Su, 4 Lichun Yang, 5 Juhua He, 6 Guihua Cui 1 1 Department of Ultrasound, Anning First People's Hospital, Kunming City, People's Republic of China; 2 Department of Radiology, Anning First People's Hospital, Kunming City, People's Republic of China; 3 Department of Ultrasound, Kunming City Maternal and Child Health Hospital, Kunming City, People's Republic of China; 4 Department of Ultrasound, Yulong People's Hospital, Lijiang City, People's Republic of China; 5 Department of Ultrasound, Yunnan Cancer Hospital, Kunming City, People's Republic of China; 6 Department of Function Examination, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming City, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chao Song, Department of Radiology, Anning First People's Hospital, Ganghe South Road, Anning City, Kunming City, Yunnan Province, 650302, People's Republic of China, Tel + 86-13908848395, Email Hongjiang Zhang, Department of Ultrasound, Anning First People's Hospital, Ganghe South Road, Anning City, Kunming City, Yunnan Province, 650302, People's Republic of China, Tel +86- 13308809792, Email Background: Axillary lymph node dissection (ALND) can be safely avoided in women with T1 or T2 primary invasive breast cancer (BC) and one to two metastatic sentinel lymph nodes (SLNs). However, cancellation of ALND based solely on SLN biopsy (SLNB) may lead to adverse outcomes. Therefore, preoperative assessment of LN tumor burden becomes a new focus for ALN status. Objective: This study aimed to develop and validate a nomogram incorporating the radiomics score (rad-score) based on automated breast ultrasound system (ABUS) and other clinicopathological features for evaluating the ALN status in patients with early-stage BC preoperatively. Methods: Totally 354 and 163 patients constituted the training and validation cohorts. They were divided into ALN low burden (< 3 metastatic LNs) and high burden (≥ 3 metastatic LNs) based on the histopathological diagnosis. The radiomics features of the segmented breast tumor in ABUS images were extracted and selected to generate the rad-score of each patient. These rad-scores, along with the ALN burden predictors identified from the clinicopathologic characteristics, were included in the multivariate analysis to establish a nomogram. It was further evaluated in the training and validation cohorts. Results: High ALN burdens accounted for 11.2% and 10.8% in the training and validation cohorts. The rad-score for each patient was developed based on 7 radiomics features extracted from the ABUS images. The radiomics nomogram was built with the rad-score, tumor size, US-reported LN status, and ABUS retraction phenomenon. It achieved better predictive efficacy than the nomogram without the rad-score and exhibited favorable discrimination, calibration and clinical utility in both cohorts. Conclusion: We developed an ABUS-based radiomics nomogram for the preoperative prediction of ALN burden in BC patients. It would be utilized for the identification of patients with low ALN burden if further validated, which contributed to appropriate axillary treatment and might avoid unnecessary ALND. Keywords: axillary lymph node, sentinel lymph node biopsy, invasive breast cancer, radiomics, nomogram, automated breast ultrasound system, tumor burden Accurate assessment of axillary lymph node (ALN) status is of great significance for clinical staging, treatment strategies, and prognosis evaluation in patients with breast cancer (BC). 1,2 Since 2017, the American Society of Clinical Oncology has updated the clinical practice guidelines based on the results of the Z0011 trials. Declares that axillary lymph node dissection (ALND) is no longer necessary for women with T1 or T2 primary invasive BC and one to two metastatic sentinel lymph nodes (SLNs) who are planning to undergo breast-conserving surgery with whole-breast radiotherapy. 3,4 However, SLN biopsy (SLNB) has a false-negative rate of roughly 10% to diagnose the metastatic LNs, 5,6 which means relying solely on the results of SLNB increases the risk of recurrence. Therefore, preoperative assessment of LN tumor burden rather than metastasis has become a new focus for ALN status. Ultrasound (US) is currently one of the primary non-invasive imaging modalities for determining ALN status. 7 However, studies have already proved that the diagnosis of ALN metastasis (ALNM) only by ultrasound is insufficient.< -Abstract Truncated-